FDA: EUAs for COVID-19 Lab Tests Will Continue after PHE Ends
Agency says it will continue to have authority to clear new lab tests and other COVID-19 products on an emergency basis even after the PHE ends.
Agency says it will continue to have authority to clear new lab tests and other COVID-19 products on an emergency basis even after the PHE ends.
A look at the US end-of-emergency game plan and how it will impact lab compliance.
FDA will still be able to issue EUAs for COVID-19 tests after May 11.
Your current COVID-19 testing arrangements may no longer be compliant on May 11.
As the outbreak continues to grow in countries that have not historically seen monkeypox cases, testing companies are stepping up.